Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/23/202410:18PMBusiness WireiStaging reveals Next Generation MR experiences at VivaTech 2024.
05/23/202410:10PMBusiness WireMitsubishi Electric to Establish Vietnamese JV for FA Products
05/23/202410:00PMGlobeNewswire Inc.Fairfax Announces the Passing of Ramaswamy AthappanTSX:FFH.UFairfax Financial Holdings Limited
05/23/202410:00PMGlobeNewswire Inc.Fairfax Announces the Passing of Ramaswamy AthappanFFH-U
05/23/202410:00PMGlobeNewswire Inc.Fairfax Announces the Passing of Ramaswamy AthappanTSX:FFHFairfax Financial Holdings Limited
05/23/20249:55PMPR Newswire (US)Azul and GOL Announce Codeshare AgreementNYSE:AZULAzul SA
05/23/20249:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MREOMereo BioPharma Group PLC
05/23/20249:52PMPR Newswire (Canada)Rappel du gobelet NÜTRL de la marque Sunscope au Canada
05/23/20249:50PMBusiness Wireセルトリオン、欧州委員会からオマリズマブ バイオシミラー「Omlyclo®(CT-P39)」の承認を取得 – 欧州初・唯一の承認
05/23/20249:49PMGlobeNewswire Inc.Imperial Announces Voting Results for the Election of DirectorsTSX:IIIImperial Metals Corporation
05/23/20249:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:JOBGEE Group Inc
05/23/20249:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:JOBGEE Group Inc
05/23/20249:49PMBusiness WireCelltrion riceve l'approvazione della Commissione europea per Omlyclo® (CT-P39), il primo e unico farmaco biosimilare di omalizumab approvato in Europa
05/23/20249:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARVNArvinas Inc
05/23/20249:48PMPR Newswire (US)LENNAR DFW DIVISION HOSTS HOPEKIDS EVENT FOR CHILDREN WITH LIFE-THREATENING MEDICAL CONDITIONS AT KIDZANIA USA
05/23/20249:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TMCWWTMC the Metals Company Inc
05/23/20249:44PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
05/23/20249:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PETWWWag Group Company
05/23/20249:44PMPR Newswire (Canada)Sunscope Recalls NÜTRL-Branded Tumbler Cup in Canada
05/23/20249:43PMPR Newswire (US)What made ASML so successful today: DIGITIMES Asia's Q&A with Dutch Journalist and author Marc Hijink
05/23/20249:42PMBusiness WireThe World's First Five-Terminal Flexible DC Transmission Project is Undergoing a Complete Overhaul
05/23/20249:37PMGlobeNewswire Inc.Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram
05/23/20249:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MDGLMadrigal Pharmaceuticals Inc
05/23/20249:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRPBaldwin Insurance Group Inc
05/23/20249:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRPBaldwin Insurance Group Inc
05/23/20249:31PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:INSEInspired Entertainment Inc
05/23/20249:31PMPR Newswire (US)IEHP's newly announced Community Wellness Center adds more heart to the city of San Bernardino
05/23/20249:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYPLPayPal Holdings Inc
05/23/20249:26PMBusiness WireCelltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
05/23/20249:21PMPR Newswire (US)/C O R R E C T I O N -- IDEAYA Biosciences, Inc./NASDAQ:IDYAIDEAYA Biosciences Inc